NCT07053020 2026-03-04A Phase 1b/2 Open-label, Dose-ranging Safety and Efficacy Study of Oral Cladribine in Patients With Acute Myeloid Leukemia (AML)M.D. Anderson Cancer CenterPhase 1/2 Not yet recruiting58 enrolled
NCT07387926 2026-02-04Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)NovartisPhase 1/2 Not yet recruiting50 enrolled